The clinical use of gabapentin in bipolar spectrum disorders

Journal of Affective Disorders

Volumn 75, Issue 1, 2003, Pages 83-91

  Carta, Mauro Giovanni ^a   Hardoy, Maria Carolina ^a   Hardoy, Maria Julieta ^b   Grunze, Heinz ^c   Carpiniello, Bernardo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Affective disorders; Anticonvulsants; Antiepileptics; Bipolar disorder; Gabapentin; Mood stabilizers

Indexed keywords

GABAPENTIN; MOOD STABILIZER; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; COMORBIDITY; COMPUTER ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; DRUG USE; HUMAN; MAJOR DEPRESSION; MANIA; MEDICAL LITERATURE; MONOTHERAPY; MOOD DISORDER; ORGANIZATION; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE;

EID: 0038012650     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00046-0     Document Type: Review

References (61)

1. Alberti G.G., Garini R., Marzolini M.N., Belz J., Greco M.I., Maresca G. Efficacy and tolerability of gabapentin and valproate in the neuroleptic treatment of acute manic syndromes. Eur. Neuropsychopharmacol. 9:(Suppl. 5):1999;S210-211.
2. Altshuler L.L., Keck P.E., McElroy S.L., et al. Gabapentin in the treatment of refractory bipolar disorders. Bipolar Disord. 1:1999;342-354.
3. Akiskal H.S., Bourgeois M.L., Angst J., Post R., Moller H., Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorder. J. Affect. Disord. 59:(Suppl. 1):2000;S5-S30.
4. Berezovkaya, A., 1999. Effectiveness of gabapentin in a broad range of psychiatric diagnosis. 152th American Psychiatric Association Annual Meeting, Washington DC, NR731:275.
5. Bennet J., Goldman W.T., Suppes T. Gabapentin for treatment of bipolar and schizoaffective disorders. J. Clin. Psychopharmacol. 17:1997;141-142. letter.
6. Bozikas V., Pehikis P., Phoces C. The use of Gabapentin in the treatment of a patient with bipolar disorder and hepatic dysfunction. Arch. Hellenic Med. 16:1999;602-604.
7. Cabras P.L., Hardoy M.J., Hardoy M.C., Carta M.G. Clinical experience with gabapentin in patients with bipolar and schizoaffective disorder: results of an open label study. J. Clin. Psychiatry. 60:1999;245-248.
8. Carta, M.G., Hardoy, M.J., Hardoy, M.C., Carpiniello, B., Cabras, P.L., 1998a. Gabapentin in mental retardation with bipolar disorders. 151th American Psychiatric Association Annual Meeting, Toronto, NR27:75.
9. Carta M.G., Mameli F., Hardoy M.C. Learning disabilities and bipolar spectrum disorders: the use of mood stabilizers. Pychiatric Networks. 1-2:1998;7-20.
10. Carta M.G., Hardoy M.J., Hardoy M.C., Dessì I., Carpiniello B. Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders. J. Intellect. Disabil. Res. 45:2001;139-145.
11. Crockatt, J., Greiner, M., Clift, L., Pande, A., 1998. Treatment of panic disorder with gabapentin. 38th Annual Meeting, New Clinical Drug Evaluation Unit Program, Boca Raton, FL.
12. Cora-Locatelli G., Greenberg B.D., Martin J.D., Murphy D.L. Rebound psychiatric and physical symptoms after gabapentin discontinuation. J. Clin. Psychiatry. 59:1998;131.
13. Erfurth A., Kammerer C., Grunze H., et al. An open label study of gabapentin in the treatment of acute mania. J. Psychiatr. Res. 32:1998;261-264.
14. Ferrier I.N. Lamotrigine and gabapentin. Alternative in the treatment of bipolar disorder. Neuropsychobiology. 38:1998;192-197.
15. Frye, M., Ketter, A.T., Osuch, E.A., Kimbrell, T.A., Speer, A.M., Dunn, R.M., Post, M.R., 1998. Gabapentin and lamotrigine monotherapy in mood disorder: an update. American Psychiatric Association Annual Meeting, N77D:150.
16. Frye M., Ketter T.A., Kimbrell T.A., et al. A placebo controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Clin. Psychopharmacol. 20:2000;607-614.
17. Garonna F., Meneghin T., Bova F. Efficacia e tollerabilità di gabapentin nel trattamento di pazienti con disturbo bipolare: una analisi retrospettiva. Giorn. Ital. Psicopat. 2:1998;269-272.
18. Ghaemi S.N., Katzof J.J., Desai S.P., et al. Gabapentin treatment of mood disorders: a preliminary study. J. Clin. Psychiatry. 59:1998;426-429.
19. Ghaemi S.N., Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers. Harv. Rev. Psychiatry. 8:2000;1-7.
20. Grunze H., Erfurth A., Amann B., et al. Gabapentin in der Behandlung der akuten Manie. Fortschr. Neurol. Psychiatr. 67:1999;1-5.
21. Guille, C., 1999. Gabapentin versus placebo as adjunctive treatment for acute mania and mixed states in Bipolar Disorders. American Psychiatric Association, Annual Meeting, NR10:63.
22. Hardoy, M.C., Hardoy, M.J., Carta, M.G., Cabras, P.L., 1998. Gabapentin for aggressive behavior. 151th American Psychiatric Association Annual Meeting, Toronto, NR67:85.
23. Hardoy M.J., Hardoy M.C., Carta M.G., Cabras P.L. Gabapentin in bipolar disorders: does a specific effect on hostility exist? Psychiatric Networks. 1-2:1998;60-64.
24. Hardoy M.C., Hardoy M.J., Carta M.G., Cabras P.L. Gabapentin as a promising treatment for antipsychotic-induced movement disorders in schizoaffective and bipolar patients. J. Affect. Disord. 54:1999;315-317.
25. Hardoy M.J., Hardoy M.C., Carta M.G., Cabras P.L. Gabapentin in the treatment of bipolar disorders. Bipolar Disord. 1:1999;S1-34.
26. Hauck A., Bhaumick S. Hypomania induced by GBP. Br. J. Psychiatry. 167:1995;549.
27. Hatzimanolis J., Lykoura L., Oulis P., Christodoulou G.N. Gabapentin as monotherapy in the treatment of acute mania. Eur. Neuropsychopharmacol. 9:(3):1999;257-258.
28. Kelly K. Gabapentin. Antiepileptic mechanism of action. Neuropsychobiology. 38:1998;139-144.
29. Knoll J., Stegman K., Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J. Affect. Disord. 49:1998;229-233.
30. Kumaran, T.S., Shetty, M.K., Lynn, D.J., 1997. Gabapentin for mood instability associated with migraine. 150th American Psychiatric Association Annual Meeting, San Diego, NR130.
31. Marcotte, D.B., Fogleman, L., Wolfe, N., et al., 1997. Gabapentin: an effective therapy for patients with bipolar affective disorder. 150th American Psychiatric Association Annual Meeting, San Diego, NR:261.
32. Maurer I., Volz H.P., Saurer H. Gabapentin leads to remission of somatoform pain disorder with major depression. Pharmacopsychiatry. 32:1999;255-257.
33. Mauri M.C., Laini V., Scalvini M., et al. Gabapentin, an alternative drug in the prophylaxis of bipolar disorders: preliminary data. Eur. Neuropsychopharmacol. 8:(Suppl. 2):1998;S181.
34. McElroy S.L., Soutullo C.A., Keck P.E. Jr., Kmetz G.F. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann. Clin. Psychiatry. 9:1997;99-103.
35. Myrick H., Malcom R., Brady K.T. Gabapentin treatment of alcohol withdrawal. Am. J. Psychiatry. 157:2000;151.
36. Olson W.L., Gruenthal M., Mueller M.E., Olson W.H. Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial. Am. J. Med. 102:1997;60-66.
37. Pacileo A., Piro A. Gabapentin in psychiatric patients committed to prison. Eur. Neuropsychopharmacol. 9:(Suppl. 5):1999;S355.
38. Pande, A.C., 1999. Combination treatment in bipolar disorders, Bipolar Disord. 1(Suppl.) 1-17.
39. Pande A.C., Davidson J., Jefferson J. Treatment of social phobia with gabapentin: a placebo controlled study. J. Clin. Psychopharmacol. 19:1999;341-348.
40. Pande A.C., Crockatt J.G., Janney C.A., Werth J.L., Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2:2000;249-255.
41. Parisi M., Janiri L., Rullo S., et al. Gabapentin in drug/alcohol dependent inpatients with comorbid psychiatric disorders and subsequent follow-up study. Eur. Neuropsychopharmacol. 9:(Suppl. 5):1999;S338.
42. Perugi G., Toni C., Ruffolo G., Sartini S., Simonini E., Akiskal H. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Pharmacopsychiatry. 32:1999;136-141.
43. Pratikakis, N., Koutouvidis, N., Kinakis, S., et al., 1999. A clinical experience with gabapentin in general hospital. XI World Congress of Psychiatry, Hamburg, Vol. II, PO 156:127.
44. Raja M., Azzoni A. Open naturalistic study of adjunctive gabapentin in the treatment of bipolar spectrum disorder. Eur. Neuropsychopharmacol. 9:(Suppl. 5):1999;S249-250.
45. Ryback R.S., Brodsky L., Munasifi F. Gabapentin in bipolar disorders. J. Neuropsychiatry Clin. Neurosci. 9:1997;301. letter.
46. Schaffer C.B., Schaffer L.C. Gabapentin in the treatment of bipolar disorder. Am. J. Psychiatry. 154:1997;291-292. letter.
47. Schaffer C.B., Schaffer L.C. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment. J. Affect. Disord. 55:1999;237-240.
48. Sheldon L. Gabapentin in psychiatric geriatric patients. Can. J. Psychiatry. 43:1998;422-423. letter.
49. Shetty, M.K., Lynn, D.J., Kumaran, T.S., 1997. Gabapentin for mood instability associated with migraine. Second International Conference on Bipolar Disorder. Western Psychiatric Institute and Clinic (poster # 50), Pittsburgh, PA, USA.
50. Short C., Cooke L. Hypomania induced by gabapentin. Br. J. Psychiatry. 166:1995;679-680.
51. Sokolski K.N., Green C., Maris D.E., DeMet E.M. Gabapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology. Ann. Clin. Psychiatry. 11:1999;217-222.
52. Stanton S.P., Keck P.E. Jr., McElroy S.L. Treatment of acute mania with gabapentin. Am. J. Psychiatry. 154:1997;287. letter.
53. Soutullo C.A., Casulo L.S., Keck P.E. Jr. Gabapentin in the treatment of adolescent mania: a case report. J. Child Adolesc. Psychopharmacol. 8:1998;81-85.
54. Taylor C.P., Gee N.S., Su T.Z., et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
55. Vieta E., Martnez-Aran A., Nieto E., Colom F., Reinares M., Bernabarre A., Gastò C. Adjunctive Gabapentin treatment of bipolar disorder. Eur. Psychiatry. 15:2000;433-437.
56. Yasmin, S., 2000. Adjunctive gabapentin in treatment of resistant depression. American Psychiatric Association Annual Meeting, Chicago, NR153:97.
57. Yasmin S., Carpenter L.L., Siniscalchi J.M., Price L.H. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. J. Affect. Disord. 63:2000;243-247.
58. Young L.T., Robb J.C., Patelis Siotis I., et al. Acute treatment of bipolar depression with gabapentin. Biol. Psychiatry. 42:1997;851-853.
59. Young L.T., Robb J.C., Hasey G.M., et al. Gabapentin as an adjunctive treatment in bipolar disorder. J. Affect. Disord. 55:1999;73-77.
60. Wang, P.W., 2000. Gabapentin in bipolar depression. American Psychiatric Association Annual Meeting, Chicago, NR151:97.
61. Zaffora, C., 1999. Gabapentin in patients with aggressive symptoms. American Psychiatric Association Annual Meeting, Washington, DC, NR660:255.